Respiratory viruses: their importance and lessons learned from COVID-19

Area of Science:

• Pulmonology and Infectious Diseases
• Virology and Epidemiology

Background:

• Respiratory virus infections pose significant global health risks, often leading to severe illness and acute respiratory distress syndrome (ARDS).
• High-risk populations, including the elderly and individuals with comorbidities, face poorer outcomes from these infections.
• Limited effective antiviral treatments and a need for better understanding of airborne transmission highlight critical gaps in managing severe viral lung infections.

Approach:

• This review synthesizes current knowledge on the epidemiology, diagnosis, clinical characteristics, management, and prognosis of severe respiratory viral infections.
• It emphasizes the importance of early diagnosis, risk stratification, and the potential role of biomarkers in clinical decision-making.
• The review also addresses the significance of airborne transmission and the need for improved mitigation strategies.

Key Points:

• Severe respiratory viral infections can rapidly progress to ARDS, with significant mortality and morbidity.
• Effective management hinges on early detection, accurate risk assessment, and timely therapeutic interventions.
• Biomarkers offer potential for reliable, accessible data to guide clinical care and improve patient outcomes.
• Understanding airborne transmission dynamics is vital for public health interventions.

Conclusions:

• There is an urgent need for enhanced research into severe respiratory viral infections to improve patient care and outcomes.
• Developing novel antiviral therapies and diagnostic tools, alongside a deeper understanding of transmission, is paramount.
• Integrated approaches combining epidemiological insights, clinical management, and biomarker discovery are essential for combating the impact of respiratory viruses.